367 related articles for article (PubMed ID: 32467069)
21. Crossroads of telomere biology and anticancer drug discovery.
Seimiya H
Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
[TBL] [Abstract][Full Text] [Related]
22. Recent Developments in Small-Molecule Ligands of Medicinal Relevance for Harnessing the Anticancer Potential of G-Quadruplexes.
Savva L; Georgiades SN
Molecules; 2021 Feb; 26(4):. PubMed ID: 33562720
[TBL] [Abstract][Full Text] [Related]
23. G-Quadruplex-Forming Aptamers-Characteristics, Applications, and Perspectives.
Roxo C; Kotkowiak W; Pasternak A
Molecules; 2019 Oct; 24(20):. PubMed ID: 31640176
[TBL] [Abstract][Full Text] [Related]
24. Ligands stimulating antitumour immunity as the next G-quadruplex challenge.
Miglietta G; Marinello J; Russo M; Capranico G
Mol Cancer; 2022 Sep; 21(1):180. PubMed ID: 36114513
[TBL] [Abstract][Full Text] [Related]
25. Affinity Chromatography-Based Assays for the Screening of Potential Ligands Selective for G-Quadruplex Structures.
Platella C; Napolitano E; Riccardi C; Musumeci D; Montesarchio D
ChemistryOpen; 2022 May; 11(5):e202200090. PubMed ID: 35608081
[TBL] [Abstract][Full Text] [Related]
26. Design of selective G-quadruplex ligands as potential anticancer agents.
Tan JH; Gu LQ; Wu JY
Mini Rev Med Chem; 2008 Oct; 8(11):1163-78. PubMed ID: 18855731
[TBL] [Abstract][Full Text] [Related]
27. Topologies of G-quadruplex: Biological functions and regulation by ligands.
Ma Y; Iida K; Nagasawa K
Biochem Biophys Res Commun; 2020 Oct; 531(1):3-17. PubMed ID: 31948752
[TBL] [Abstract][Full Text] [Related]
28. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
29. Quadruplex-forming oligonucleotides as tools in anticancer therapy and aptamers design: energetic aspects.
Petraccone L; Barone G; Giancola C
Curr Med Chem Anticancer Agents; 2005 Sep; 5(5):463-75. PubMed ID: 16178773
[TBL] [Abstract][Full Text] [Related]
30. Natural Alkaloids and Heterocycles as G-Quadruplex Ligands and Potential Anticancer Agents.
Che T; Wang YQ; Huang ZL; Tan JH; Huang ZS; Chen SB
Molecules; 2018 Feb; 23(2):. PubMed ID: 29473874
[TBL] [Abstract][Full Text] [Related]
31. G-quadruplexes: targets and tools in anticancer drug design.
Düchler M
J Drug Target; 2012 Jun; 20(5):389-400. PubMed ID: 22424091
[TBL] [Abstract][Full Text] [Related]
32. Telomeric G-quadruplex architecture and interactions with potential drugs.
Sissi C; Palumbo M
Curr Pharm Des; 2014; 20(41):6489-509. PubMed ID: 24975609
[TBL] [Abstract][Full Text] [Related]
33. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
34. Discovery and development of anticancer aptamers.
Ireson CR; Kelland LR
Mol Cancer Ther; 2006 Dec; 5(12):2957-62. PubMed ID: 17172400
[TBL] [Abstract][Full Text] [Related]
35. Unlocking G-Quadruplexes as Targets and Tools against COVID-19.
Qin G; Zhao C; Yang J; Wang Z; Ren J; Qu X
Chin J Chem; 2022 Dec; ():. PubMed ID: 36711116
[TBL] [Abstract][Full Text] [Related]
36. G-quadruplex ligands as therapeutic agents against cancer, neurological disorders and viral infections.
Yan MP; Wee CE; Yen KP; Stevens A; Wai LK
Future Med Chem; 2023 Nov; 15(21):1987-2009. PubMed ID: 37933551
[TBL] [Abstract][Full Text] [Related]
37. EMICORON: A multi-targeting G4 ligand with a promising preclinical profile.
Porru M; Zizza P; Franceschin M; Leonetti C; Biroccio A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1362-1370. PubMed ID: 27838395
[TBL] [Abstract][Full Text] [Related]
38. Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential.
Gatto B; Palumbo M; Sissi C
Curr Med Chem; 2009; 16(10):1248-65. PubMed ID: 19355883
[TBL] [Abstract][Full Text] [Related]
39. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.
Bates PJ; Laber DA; Miller DM; Thomas SD; Trent JO
Exp Mol Pathol; 2009 Jun; 86(3):151-64. PubMed ID: 19454272
[TBL] [Abstract][Full Text] [Related]
40. Developing Novel G-Quadruplex Ligands: from Interaction with Nucleic Acids to Interfering with Nucleic Acid⁻Protein Interaction.
Sun ZY; Wang XN; Cheng SQ; Su XX; Ou TM
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
